U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Trichilemmoma

MedGen UID:
90753
Concept ID:
C0334263
Neoplastic Process
Synonym: Tricholemmoma
SNOMED CT: Trichilemmoma (274900003); Trichilemmoma (46199002); Tricholemmoma (274900003); Tricholemmoma (46199002)
 
HPO: HP:0012844

Definition

A benign tumor originating from the outer root sheath of the hair follicle. [from HPO]

Conditions with this feature

Cowden syndrome 4
MedGen UID:
767431
Concept ID:
C3554517
Disease or Syndrome
\n\nThe features of Cowden syndrome overlap with those of another disorder called Bannayan-Riley-Ruvalcaba syndrome. People with Bannayan-Riley-Ruvalcaba syndrome also develop hamartomas and other noncancerous tumors.  Some people with Cowden syndrome have relatives diagnosed with Bannayan-Riley-Ruvalcaba syndrome, and other affected individuals have the characteristic features of both conditions. Based on these similarities, researchers have proposed that Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome represent a spectrum of overlapping features known as PTEN hamartoma tumor syndrome (named for the genetic cause of the conditions) instead of two distinct conditions.\n\nSome people do not meet the strict criteria for a clinical diagnosis of Cowden syndrome, but they have some of the characteristic features of the condition, particularly the cancers. These individuals are often described as having Cowden-like syndrome. Both Cowden syndrome and Cowden-like syndrome are caused by mutations in the same genes.\n\nCowden syndrome is associated with an increased risk of developing several types of cancer, particularly cancers of the breast, a gland in the lower neck called the thyroid, and the lining of the uterus (the endometrium). Other cancers that have been identified in people with Cowden syndrome include kidney cancer, colorectal cancer, and an agressive form of skin cancer called melanoma. Compared with the general population, people with Cowden syndrome develop these cancers at younger ages, often beginning in their thirties or forties. People with Cowden syndrome are also more likely to develop more than one cancer during their lifetimes compared to the general population. Other diseases of the breast, thyroid, and endometrium are also common in Cowden syndrome. Additional signs and symptoms can include an enlarged head (macrocephaly) and a rare, noncancerous brain tumor called Lhermitte-Duclos disease. A small percentage of affected individuals have delayed development, intellectual disability, or autism spectrum disorder, which can affect communication and social interaction.\n\nAlmost everyone with Cowden syndrome develops hamartomas. These growths are most commonly found on the skin and mucous membranes (such as the lining of the mouth and nose), but they can also occur in the intestine and other parts of the body. The growth of hamartomas on the skin and mucous membranes typically becomes apparent by a person's late twenties.\n\nCowden syndrome is a genetic disorder characterized by multiple noncancerous, tumor-like growths called hamartomas and an increased risk of developing certain cancers.
Cowden syndrome 7
MedGen UID:
908796
Concept ID:
C4225179
Disease or Syndrome
Cowden syndrome is a genetic disorder characterized by multiple noncancerous, tumor-like growths called hamartomas and an increased risk of developing certain cancers.\n\nAlmost everyone with Cowden syndrome develops hamartomas. These growths are most commonly found on the skin and mucous membranes (such as the lining of the mouth and nose), but they can also occur in the intestine and other parts of the body. The growth of hamartomas on the skin and mucous membranes typically becomes apparent by a person's late twenties.\n\nCowden syndrome is associated with an increased risk of developing several types of cancer, particularly cancers of the breast, a gland in the lower neck called the thyroid, and the lining of the uterus (the endometrium). Other cancers that have been identified in people with Cowden syndrome include kidney cancer, colorectal cancer, and an agressive form of skin cancer called melanoma. Compared with the general population, people with Cowden syndrome develop these cancers at younger ages, often beginning in their thirties or forties. People with Cowden syndrome are also more likely to develop more than one cancer during their lifetimes compared to the general population. Other diseases of the breast, thyroid, and endometrium are also common in Cowden syndrome. Additional signs and symptoms can include an enlarged head (macrocephaly) and a rare, noncancerous brain tumor called Lhermitte-Duclos disease. A small percentage of affected individuals have delayed development, intellectual disability, or autism spectrum disorder, which can affect communication and social interaction.\n\nSome people do not meet the strict criteria for a clinical diagnosis of Cowden syndrome, but they have some of the characteristic features of the condition, particularly the cancers. These individuals are often described as having Cowden-like syndrome. Both Cowden syndrome and Cowden-like syndrome are caused by mutations in the same genes.\n\nThe features of Cowden syndrome overlap with those of another disorder called Bannayan-Riley-Ruvalcaba syndrome. People with Bannayan-Riley-Ruvalcaba syndrome also develop hamartomas and other noncancerous tumors.  Some people with Cowden syndrome have relatives diagnosed with Bannayan-Riley-Ruvalcaba syndrome, and other affected individuals have the characteristic features of both conditions. Based on these similarities, researchers have proposed that Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome represent a spectrum of overlapping features known as PTEN hamartoma tumor syndrome (named for the genetic cause of the conditions) instead of two distinct conditions.\n\n

Professional guidelines

PubMed

Jin M, Hampel H, Pilarski R, Zhou X, Peters S, Frankel WL
Am J Dermatopathol 2013 Aug;35(6):637-40. doi: 10.1097/DAD.0b013e31827e28f7. PMID: 23715080

Recent clinical studies

Etiology

Ye Q, Wu Q, Jia M, Li FZ, Fang S
Dermatology 2023;239(1):140-147. Epub 2022 Sep 9 doi: 10.1159/000526143. PMID: 36088908
Pointdujour-Lim R, Marous MR, Satija CE, Douglass AM, Eagle RC Jr, Shields JA, Shields CL
Ophthalmic Plast Reconstr Surg 2017 Jul/Aug;33(4):233-236. doi: 10.1097/IOP.0000000000000816. PMID: 27811637
Tellechea O, Cardoso JC, Reis JP, Ramos L, Gameiro AR, Coutinho I, Baptista AP
An Bras Dermatol 2015 Nov-Dec;90(6):780-96; quiz 797-8. doi: 10.1590/abd1806-4841.20154114. PMID: 26734858Free PMC Article
Mertens RB, de Peralta-Venturina MN, Balzer BL, Frishberg DP
Am J Dermatopathol 2015 Dec;37(12):885-91. doi: 10.1097/DAD.0000000000000306. PMID: 26595821Free PMC Article
Jin M, Hampel H, Pilarski R, Zhou X, Peters S, Frankel WL
Am J Dermatopathol 2013 Aug;35(6):637-40. doi: 10.1097/DAD.0b013e31827e28f7. PMID: 23715080

Diagnosis

Tellechea O, Cardoso JC, Reis JP, Ramos L, Gameiro AR, Coutinho I, Baptista AP
An Bras Dermatol 2015 Nov-Dec;90(6):780-96; quiz 797-8. doi: 10.1590/abd1806-4841.20154114. PMID: 26734858Free PMC Article
Maher EE, Vidal CI
Cutis 2015 Aug;96(2):81, 104-6. PMID: 26367753
Cui A, Mei Z, Cui L
Int J Clin Exp Pathol 2015;8(3):3349-53. Epub 2015 Mar 1 PMID: 26045866Free PMC Article
Jin M, Hampel H, Pilarski R, Zhou X, Peters S, Frankel WL
Am J Dermatopathol 2013 Aug;35(6):637-40. doi: 10.1097/DAD.0b013e31827e28f7. PMID: 23715080
Chan P, White SW, Pierson DL, Rodman OG
J Dermatol Surg Oncol 1979 Jan;5(1):58-9. doi: 10.1111/j.1524-4725.1979.tb00605.x. PMID: 759462

Therapy

Bae SB, Lee KK, Kim JS, Lee JH, Lee NS, Lee GT, Park SK, Won JH, Baick SH, Hong DS, Lee DW, Park HS
Korean J Intern Med 2001 Mar;16(1):40-3. doi: 10.3904/kjim.2001.16.1.40. PMID: 11417304Free PMC Article
Tellechea O, Reis JP, Baptista AP
Am J Dermatopathol 1992 Apr;14(2):107-4. doi: 10.1097/00000372-199204000-00004. PMID: 1373583

Prognosis

Cui A, Mei Z, Cui L
Int J Clin Exp Pathol 2015;8(3):3349-53. Epub 2015 Mar 1 PMID: 26045866Free PMC Article
Jin M, Hampel H, Pilarski R, Zhou X, Peters S, Frankel WL
Am J Dermatopathol 2013 Aug;35(6):637-40. doi: 10.1097/DAD.0b013e31827e28f7. PMID: 23715080
Plaza JA, Ortega PF, Stockman DL, Suster S
J Cutan Pathol 2010 Apr;37(4):403-10. doi: 10.1111/j.1600-0560.2010.01517.x. PMID: 20377670
Minami Y, Uede K, Sagawa K, Kimura A, Tsuji T, Furukawa F
Br J Dermatol 2004 Jul;151(1):165-9. doi: 10.1111/j.1365-2133.2004.06079.x. PMID: 15270886
Illueca C, Monteagudo C, Revert A, Llombart-Bosch A
J Cutan Pathol 1998 Sep;25(8):435-9. doi: 10.1111/j.1600-0560.1998.tb01770.x. PMID: 9826169

Clinical prediction guides

Zwai HA, Al-Attar AR, Morsi AE, El-Fetouh MSA
Open Vet J 2024 Jan;14(1):481-499. Epub 2024 Jan 31 doi: 10.5455/OVJ.2024.v14.i1.44. PMID: 38633166Free PMC Article
Chaudet KM, Stagner AM, Nazarian RM
Am J Dermatopathol 2022 Dec 1;44(12):886-890. Epub 2022 Sep 27 doi: 10.1097/DAD.0000000000002302. PMID: 36197047
Tsai JH, Huang WC, Jhuang JY, Jeng YM, Cheng ML, Chiu HY, Kuo KT, Liau JY
Br J Dermatol 2014 Nov;171(5):1073-7. Epub 2014 Sep 30 doi: 10.1111/bjd.13143. PMID: 24890286
Jin M, Hampel H, Pilarski R, Zhou X, Peters S, Frankel WL
Am J Dermatopathol 2013 Aug;35(6):637-40. doi: 10.1097/DAD.0b013e31827e28f7. PMID: 23715080
Tsutsui M, Iizuka H, Ohkawara A, Adachi K, Kanzaki T
Arch Dermatol Res 1987;279(8):530-5. doi: 10.1007/BF00413285. PMID: 2449140

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...